Literature DB >> 9651350

Identification of a novel cadherin (vascular endothelial cadherin-2) located at intercellular junctions in endothelial cells.

P Telo'1, F Breviario, P Huber, C Panzeri, E Dejana.   

Abstract

Endothelial cells express two major cadherins, VE- and N-cadherins, but only the former consistently participates in adherens junction organization. In heart microvascular endothelial cells, we identified a new member of the cadherin superfamily using polymerase chain reaction. The entire putative coding sequence was determined. Similarly to protocadherins, while the extracellular domain presented homology with other members of the cadherin superfamily, the intracellular region was unrelated either to cadherins or to any other known protein. We propose for this new protein the name of vascular endothelial cadherin-2. By Northern blot analysis, the mRNA was present only in cultured endothelial cell lines but not in other cell types such as NIH 3T3, Chinese hamster ovary, or L cells. In addition, mRNA was particularly abundant in highly vascularized organs such as lung or kidney. In endothelial cells and transfectants, this cadherin was unable to bind catenins and presented a weak association with the cytoskeleton. This new molecule shares some functional properties with VE-cadherin and other members of the cadherin family. In Chinese hamster ovary transfectants it promoted homotypic Ca2+ dependent aggregation and adhesion and clustered at intercellular junctions. However, in contrast to VE-cadherin, it did not modify paracellular permeability, cell migration, and density-dependent cell growth. These observations suggest that different cadherins may promote homophilic cell-to-cell adhesion but that the functional consequences of this interaction depend on their binding to specific intracellular signaling/cytoskeletal proteins.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9651350     DOI: 10.1074/jbc.273.28.17565

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins.

Authors:  T Kucharzik; S V Walsh; J Chen; C A Parkos; A Nusrat
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

2.  Multiple protocadherins are expressed in brain microvascular endothelial cells and might play a role in tight junction protein regulation.

Authors:  Christina Dilling; Norbert Roewer; Carola Y Förster; Malgorzata Burek
Journal:  J Cereb Blood Flow Metab       Date:  2017-01-17       Impact factor: 6.200

Review 3.  Protein Interactions at Endothelial Junctions and Signaling Mechanisms Regulating Endothelial Permeability.

Authors:  Yulia A Komarova; Kevin Kruse; Dolly Mehta; Asrar B Malik
Journal:  Circ Res       Date:  2017-01-06       Impact factor: 17.367

4.  Loss of Protocadherin-12 Leads to Diencephalic-Mesencephalic Junction Dysplasia Syndrome.

Authors:  Alicia Guemez-Gamboa; Ahmet Okay Çağlayan; Valentina Stanley; Anne Gregor; Maha S Zaki; Sahar N Saleem; Damir Musaev; Jennifer McEvoy-Venneri; Denice Belandres; Naiara Akizu; Jennifer L Silhavy; Jana Schroth; Rasim Ozgur Rosti; Brett Copeland; Steven M Lewis; Rebecca Fang; Mahmoud Y Issa; Huseyin Per; Hakan Gumus; Ayse Kacar Bayram; Sefer Kumandas; Gozde Tugce Akgumus; Emine Z Erson-Omay; Katsuhito Yasuno; Kaya Bilguvar; Gali Heimer; Nir Pillar; Noam Shomron; Daphna Weissglas-Volkov; Yuval Porat; Yaron Einhorn; Stacey Gabriel; Bruria Ben-Zeev; Murat Gunel; Joseph G Gleeson
Journal:  Ann Neurol       Date:  2018-10-04       Impact factor: 10.422

5.  Protocadherin of the liver, kidney, and colon associates with detergent-resistant membranes during cellular differentiation.

Authors:  Michael P Krahn; Sandra Rizk; Marwan Alfalah; Marc Behrendt; Hassan Y Naim
Journal:  J Biol Chem       Date:  2010-02-16       Impact factor: 5.157

6.  Protocadherin-12 cleavage is a regulated process mediated by ADAM10 protein: evidence of shedding up-regulation in pre-eclampsia.

Authors:  Stéphanie Bouillot; Emmanuelle Tillet; Guillaume Carmona; Marie-Hélène Prandini; Anne-Sophie Gauchez; Pascale Hoffmann; Nadia Alfaidy; Francine Cand; Philippe Huber
Journal:  J Biol Chem       Date:  2011-03-14       Impact factor: 5.157

7.  A case of new PCDH12 gene variants presented as dyskinetic cerebral palsy with epilepsy.

Authors:  Sato Suzuki-Muromoto; Keisuke Wakusawa; Takuya Miyabayashi; Ryo Sato; Yukimune Okubo; Wakaba Endo; Takehiko Inui; Noriko Togashi; Atsuko Kato; Hiroshi Oba; Mitsuko Nakashima; Hirotomo Saitsu; Naomichi Matsumoto; Kazuhiro Haginoya
Journal:  J Hum Genet       Date:  2018-03-19       Impact factor: 3.172

8.  Glyco-catch method: A lectin affinity technique for glycoproteomics.

Authors:  Jun Hirabayashi; Tomomi Hashidate; Ken-ichi Kasai
Journal:  J Biomol Tech       Date:  2002-12

9.  Protocadherin 12 deficiency alters morphogenesis and transcriptional profile of the placenta.

Authors:  Christine Rampon; Stéphanie Bouillot; Adriana Climescu-Haulica; Marie-Hélène Prandini; Francine Cand; Yves Vandenbrouck; Philippe Huber
Journal:  Physiol Genomics       Date:  2008-05-13       Impact factor: 3.107

10.  VE-cadherin is a critical endothelial regulator of TGF-beta signalling.

Authors:  Noemi Rudini; Angelina Felici; Costanza Giampietro; MariaGrazia Lampugnani; Monica Corada; Kendra Swirsding; Massimiliano Garrè; Stefan Liebner; Michelle Letarte; Peter ten Dijke; Elisabetta Dejana
Journal:  EMBO J       Date:  2008-03-13       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.